Summary
Very few investigations in man have been specifically devoted to the influence of sex on drug kinetics. Although the potential role of various factors such as the phase of the menstrual cycle, hormonal steroid contraceptive use, menopause or andropause is virtually never taken into account, sex-linked differences in drug kinetics do exist for a limited number of substances such as certain antibiotics, a few tricyclic antidepressants, lithium and aspirin. These sex-linked differences are relatively minor from a quantitative standpoint and appear to be due chiefly to differences in body composition and activity of circulating enzymes and hormones. On the basis of present knowledge, in general these differences in drug kinetics do not warrant modifying dosage as a function of sex.
Similar content being viewed by others
References
Birch, N.J.; Greenfield, A.A. and Hullin, R.P.: A metabolic profile of patients receiving prophylactic lithium therapy. British Journal of Pharmacology 52: 443P–444P (1974).
Bird, C.E. and Clark, A.F.: Kinetics of 3H-5-dihydrotestosterone metabolism in normal men and women and men with prostatic carcinoma; effects of estrogen administration in men. Journal of Clinical Edocrinology and Metabolism 34: 467–472 (1972).
Bjorntorp, P.; Bengtsson, C.; Blohme, G.; Jonsson, A.; Sjostrom, L.; Tibblin, E.; Tibblin, G. and Wilhelmsen, L.: Adipose tissue fat cell size and number in relation to metabolism in randomly selected middle-aged men and women. Metabolism 20; 927–935 (1971).
Blecher, T.E.; Edgar, W.M.; Melville, H.A.H. and Peel, K.R.: Transplacental passage of ampicillin. British Medical Journal 1: 137–139 (1966).
Briggs, M.H.; Vitamin A and the teratogenic risks of oral contraceptives. British Medical Journal 3: 170–171 (1974).
Buckingham, M.; Welply, G.; Miller, J.F. and Elstein, M.: Gastrointestinal absorption and transplacental transfer of amoxycillin during labour and the influence of metoclopramide. Current Medical Research and Opinion 3: 392–396 (1975).
Burrows, G.; Scoggins, B.A.; Turecek, L.R. and Davies, B.: Plasma nortriptyline and clinical response. Clinical Pharmacology and Therapeutics 16: 639–644 (1974).
Clark, A.F.; Calandra, R.S. and Bird, C.E.: Binding of testosterone and 5-α-dihydrotestosterone to plasma proteins in humans. Clinical Biochemistry 4: 89–96 (1971).
Crawford, J.S. and Rudofsky, S.: Some alterations in the pattern of drug metabolism associated with pregnancy, oral contraceptives and the newly born. British Journal of Anaesthesia 38: 446–454 (1966).
Davison, J.S.; Davison, M.C. and Hay, D.M.: Gastric emptying time in late pregnancy and labour. Journal of Obstetrics and Gynaecology of the British Commonwealth 77: 37–41 (1970).
Donatelli, L.: Eta, sesso e barbiturismo acuto. Contributo chemico e sperimentale. Archives Internationales de Pharmacodynamic et de Therapie 74: 90–111 (1947).
Eadie, M.J.; Tyrer, J.H. and Hooper, W.D.: Diphenylhydantoin dosage. Proceedings of the Australian Association of Neurology 10: 53–59 (1973).
Fisher, A.M. and Smith, M.R.: The prophylactic use of ampicillin and its transplacental passage after amniotomy. Journal of Obstetrics and Gynaecology of the British Commonwealth 74: 855–861 (1967).
Fishman, J.L.; Boyar, R.M. and Hellman, L.: The system estradiol-estrone: a sex difference in oxidation of estradiol in man. Journal of Clinical Endocrinology and Metabolism 34: 989–996 (1972).
Fraser, H.S.; Bulpitt, C.J.; Kahn, C.; Mould, G.; Mucklow, J.C. and Dollery, C.T.: Factors affecting antipyrine metabolism in West African villagers. Clinical Pharmacology and Therapeutics 20: 369–376 (1976).
Giudicelli, J.F.; Richer, C.; Berdeaux, A. and Guessous, N.: Influence of sex on the clinical pharmacology of flutiorex, a new anorectic drug. Eur. J. Clin. Pharmacol. 10: 325–330 (1976).
Gordon, G.G.; Altman, K.; Southern, A.L. and Olivo, J.: Human hepatic testosterone A-ring reductase activity: effect of medroxyprogesterone acetate Journal of Clinical Endocrinology and Metabolism 32: 457–461 (1971).
Grant, E.C.G. and Mears, E.: Mental effects of oral contraceptives. Lancet 3: 945–946 (1967).
Graupner, K.: Uber einen Untershied der Lokalanaesthetischen Wirkung von Lidocain am der Cornea mannlicher und weiblicher Versuchspersonen. Medicina experimentalis 10: 111–114 (1964).
Grossman, M.I.; Kirsner, J.B. and Gillespie, I.A.: Basal and Histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 45: 14–26 (1963).
Hammer, W. and Sjoqvist, F.: Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sciences 6: 1895–1903 (1967).
Hellman, L.; Zumoff, B.; Kessler, G.; Kara, E.; Rubin, I.L. and Rosenfield, R.S.: Reduction of cholesterol and lipids in man by ethyl-p-chlorophenoxy-isobutyrate. Annals of Internal Medicine 59: 477–494 (1963).
Hooper, W.D.; Bochner, F.; Eadie, M.J. and Tyrer, J.H.: Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic diseases. Clinical Pharmacology and Therapeutics 15: 276–282 (1974).
Houghton, G.W.; Richens, A. and Leighton, M.: Effects of age, height, weight and sex on serum phenytoin concentration in epileptic patients. British Journal of Clinical Pharmacology 2: 251–256 (1975).
Huffman, D.H.; Shoeman, D.W.; Pentikainen, P. and Azamoff, D.L.: The effect of spironolactone on antipyrine metabolism in man. Pharmacology 10: 338–344 (1973).
Hurwitz, N.: Predisposing factors in adverse reactions to drugs. British Medical Journal 1: 536–539 (1969).
Iwainsky, H.; Winsel, K.; Werner, E. and Eule, H.: On the pharmacokinetics of rifampicin during treatment with intermittent administration. II. Influence of age and sex of the patients. Scandinavian Journal of Respiratory Diseases 57: 5–11 (1976).
Jacobs, A.: Sex differences in iron absorption. Proceedings of the Nutrition Society 35: 159–162 (1976).
Johnsen, S.G.; Kampmann, J.P.; Bennett, E.P. and Jorgensen, F.S.: Enzyme induction by oral testosterone. Clinical Pharmacology and Therapeutics 20: 233–237 (1976).
Juhlin, I.: Problems in diagnosis, treatment and control of gonorrhoeal infections. Acta Dermato-Venereologica 45: 231–241 (1965).
Kampmann, J.; Molmholm-hansen, J.; Siersbaek-Nielsen, K. and Kristensen, M.: Serum creatinine and drug half-lives. Journal of the American Medical Association 223: 193 (1973).
Kellermann, G.; Luyten-Kellermann, M.; Horning, M.G. and Stafford, M.: Elimination of antipyrine and benzo: a: pyrene metabolism in cultured human lymphocytes. Clinical Pharmacology and Therapeutics 20: 72–80 (1976).
Koch-Weser, J. and Sellers, E.M.: Drug interactions with coumarin anticoagulants. New England Journal of Medicine 285: 547–558 (1971).
Loh, H.S.; Odumosu, A. and Wilson, C.W.M.: Factors influencing the metabolic availability of ascorbic acid. I. The effect of sex. Clinical Pharmacology and Therapeutics 16: 390–408 (1974).
McQueen, E.G.: Pharmacological basis of adverse drug reactions; in Avery (Ed) Drug Treatment, p. 169 (ADIS Press, Sydney; Publishing Sciences Group, Acton, Mass; Churchill Livingstone, Edinburgh 1976).
Martin, J.F.; Mikulecky, M.; Blaschike, J.F.; Waggoner, J.G.; Vergalla, J. and Berk, P.D.: Difference between the plasma indocyanine disappearance rates of normal men and women. Proceedings of the Society for Experimental Biology and Medicine 150: 612–617 (1975).
Mather, L.E.; Tucker, G.T.; Pflug, A.E.; Lindop, M.J. and Wilkerson, C.: Meperidine kinetics in man. Intravenous injection in surgical patients and volunteers. Clinical Pharmacology and Therapeutics 17: 21–30 (1975).
Menguy, R.; Desbaillets, L.; Masters, Y.F. and Okabe, S.: Evidence for a sex-linked difference in aspirin metabolism. Nature 239: 102–103 (1972).
Moody, J.P.; Tait, A.C. and Todrick, A.: Plasma levels of imipramine and desmethylimipramine during therapy. British Journal of Psychiatry 113: 183–193 (1967).
Nielsen, B.; Sorensen, A.W.; Szabo, L.; Pedersen, E.. and Scharff, A.: Kanamycin serum half-life and renal function: age and sex. Danish Medical Bulletin 20: 144–149 (1973).
Nimmo, W.S.: Drugs diseases and altered gastric emptying. Clinical Pharmacokinetics 1: 189–203 (1976).
Novak, L.P.: Ageing, total body potassium, fat free mass and cell mass in males and females between the ages 18 and 85 years. Journal of Gerontology 27: 438–443 (1972).
Odumosu, A. and Wilson, C.W.: The buccal absorption of vitamin C. Proceedings of the Nutrition Society 30: 81A–82A (1971).
O’Malley, K.; Crooks, J.; Duke, E. and Stevenson, I.H.: Effects of age and sex on human drug metabolism. British Medical Journal 3: 607–609 (1971).
O’Malley, K.; Stevenson, I.H. and Crooks, J.: Impairment of human drug metabolism by oral contraceptive steroids. Clinical Pharmacology and Therapeutics 13: 552–557 (1972).
Perrier, D. and Gibaldi, M.: Estimation of drug elimination in renal failure. Journal of Clinical Pharmacology 13: 458–462 (1973).
Prescott, I.F.: Gastrointestinal absorption of drugs. Medical Clinics of North America 48: 907–916 (1974).
Proven, G. and Canetti, G.: Les taux de rifampicine dans le serum de l’Homme. Revue de la Tuberculose (Paris) 32: 707–716 (1968).
Quinn, G.P.; Axelrod, J. and Brodie, B.B.: Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and aniline. Biochemical Pharmacology 1: 152–159 (1958).
Raskin, A.: Age-sex differences in response to antidepressant drugs. Journal of Nervous and Mental Diseases 159: 120–130 (1974).
Robinson, B.H.B.; Hawkins, J.B.; Ellis, J.E. and Moore-Robinson, M.: Decreased antucoagulant tolerance with oxymetholone. Lancet 1: 1356 (1971).
Saez, J.M.; Forest, M.G.; Morera, A.M. and Bertrand, J.: Metabolic clearance rate and blood production rate of testosterone and dihydrotestosterone in normal subjects during pregnancy and in hyperthyroidism. Journal of Clinical Investigation 51: 1226–1234 (1972).
Sato, A.; Nakajima, T.; Fukiwara, Y. and Murayama, N.: Kinetic studies on sex difference in susceptibility to chronic benzene intoxication, with special reference to body fat content. British Journal of Industrial Medicine 32: 321–328 (1975).
Schroder, G.; Abrahamsson, L.; Wasser, A.; Malmcrona, R. and Bergquist, N.: Digoxin: plasma concentration of digoxin in out-patients. Acta Medica Scandinavica 193: 215–218 (1973).
Schrogie, J.J.; Solomon, H.M. and Zieve, P.D.: Effects of oral contraceptives on vitamin K-dependent clotting activity. Clinical Pharmacology and Therapeutics 8: 670–675 (1967).
Scotti, R.: Sex differences in blood levels of some antibiotics. Chemotherapy 18: 205–211 (1973).
Sherwin, A.L.; Loynd, J.S.; Bock, G.W. and Sokolowski, C.B.: Effects of age, sex, obesity and pregnancy on plasma diphenylhydantoin levels. Epilepsia 15: 507–521 (1974).
Somani, S.M. and Khurana, R.C.: Mechanism of estrogen-ipramine interaction. Journal of the American Medical Association 223: 560 (1973).
Sotaniemi, E.A. and Huhti, E.: Half-life of intravenous tolbutamide in the serum of patients in medical wards. Annals of Clinical Research 6: 146–154 (1974).
Stern-Nielsen, L.K. and Friis, T.: Tyroksinomsaetningens aldersafhaengighed hos eutyreoide patienter. Ugeskrift for Laeger 135: 640–644 (1973).
Travers, R.; Reynolds, E.H. and Callagher, B.: Variation in response to anticonvulsants in a group of epileptic patients. Archives of Neurology 27: 29–33 (1972).
Tryding, N.E.; Nilsson, S.E.; Tufvesson, G.; Berg, R.; Carlstrom, S.; Elmfors, B. and Nilsson, J.E.: Physiological and pathological influence on serum monoamine oxidase levels. Effect of age, sex, contraceptive steroids and diabetes mellitus. Scandinavian Journal of Laboratory Investigation 23: 79–84 (1969).
Vermeulen, A. and Verdonk, L.: Studies on the binding of testosterone in human plasma. Steroids 11: 609–619 (1968).
Vesell, E.S. and Page, JG.: Genetic control of drug levels in man: phenylbutazone. Science 159: 1479–1480 (1968).
Villeneuve, A.; Gautier, J.; Jus, A. and Perron, D.: Effect of lithium on thyroid in man. Lancet 2: 502 (1973).
Vukovich, R.A.; Brannick, L.H.; Sugerman, A.A. and Neiss, E.S.: Sex differences in the intramuscular absorption and bioavailability of cephradine. Clinical Pharmacology and Therapeutics 18: 215–220 (1975).
Weiner, M.; Siddiqui, A.A.; Bostanci, N. and Dayton, P.G.: Drug interactions: the effect of combined administration on the half-life of coumarin and pyrazolone drugs in man. Federation Proceedings 24: 153 (1965).
Weiner, M.; Siddiqui, A.A.; Shahani, R.T. and Dayton, P.G.: Effects of steroids on disposition of oxyphenbutazone in man. Proceedings of the Society for Experimental Biology and Medicine 124: 1170–1173 (1967).
Whittaker, J.A. and Price-Evans, J.A.: Genetic control of phenylbutazone in man. British Medical Journal 4: 323–328 (1970).
Wild, J.; Schorah, C.J. and Smithells, R.W.: Vitamin A, pregnancy and oral contraceptives. British Medical Journal 1: 57–59 (1974).
Ziegler, D.M. and Gold, M.S.: Oxidative metabolism of tertiary amine drugs by human liver tissue. Xenobiotica 1: 325–326 (1971).
Zumoff, B.; Bradlow, H.L. and Hellman, L.: 17-oxidation of testosterone in man: absence of a sex difference. Journal of Clinical Endocrinology and Metabolism 37: 293–296 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Giudicelli, J.F., Tillement, J.P. Influence of Sex on Drug Kinetics in Man. Clin Pharmacokinet 2, 157–166 (1977). https://doi.org/10.2165/00003088-197702030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-197702030-00001